Considerations of strategies to provide influenza vaccine year round.

Vaccine
Philipp LambachMichael Pfleiderer

Abstract

There is potential for influenza vaccine programmes to make a substantial impact on severe disease in low-resource settings, however questions around vaccine composition and programmatic issues will require special attention. Some countries may benefit from immunization programmes that provide year-round supply of vaccine; however the best way to ensure adequate vaccine supply has yet to be determined. In this report, we discuss vaccine composition, availability, and programmatic issues that must be considered when developing year-round influenza immunization programmes. We then explore how these considerations have influenced immunization practices in the Latin American region as a case study. We identify three different approaches to achieve year-round supply: (1) alternating between Northern Hemisphere and Southern Hemisphere formulations, (2) extending the expiration date to permit extended use of a single hemisphere formulation, and (3) local vaccine manufacture with production timelines that align with local epidemiology. Each approach has its challenges and opportunities. The growing data suggesting high influenza disease burden in low resource countries underscores the compelling public health need to determine the best...Continue Reading

References

Jun 16, 1992·Annals of the New York Academy of Sciences·E F BlouinS A Ewing
Jan 9, 2003·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Apr 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy M UyekiUNKNOWN Alaska/Yukon Territory Respiratory Outbreak Investigation Team
Jan 18, 2005·Revista de saúde pública·Sérgio Souza da CunhaInês Dourado
Feb 24, 2006·Emerging Infectious Diseases·Angela ChowSuok Kai Chew
Jan 24, 2007·Vaccine·Marie Paule KienyKeiji Fukuda
Feb 21, 2009·Vaccine·Marie Paule Kieny, Keiji Fukuda
Sep 26, 2009·BMC Public Health·Alba María Ropero-AlvarezJon K Andrus
Dec 17, 2009·Vaccine·Ian G BarrUNKNOWN Writing Committee of the World Health Organization Consultation on Northern Hemisphere Influenza Vaccine Composition for 200
Jan 23, 2010·Biologicals : Journal of the International Association of Biological Standardization·UNKNOWN WHO
Mar 5, 2011·The Lancet Infectious Diseases·Bradford D GessnerSylvie Briand
Oct 4, 2011·Virus Research·James S Robertson, Stephen C Inglis
Apr 13, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hong ZhouDavid K Shay
Nov 15, 2012·Vaccine·Jeffrey Partridge, Marie Paule Kieny
Nov 28, 2012·The Journal of Infectious Diseases·Jennifer Michalove RadinMarc-Alain Widdowson
Jun 21, 2013·The Pan African Medical Journal·Duncan Mwangangi MathekaMarybeth Maritim
Dec 10, 2013·Western Pacific Surveillance and Response Journal : WPSAR·Dominic DwyerJeffrey Partridge
May 7, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen Y Chu, Janet A Englund
May 13, 2014·Lancet·Mark C SteinhoffLouis J Muglia
May 20, 2014·Bulletin of the World Health Organization·Nancy Cox
May 20, 2014·Bulletin of the World Health Organization·Siddhartha SahaRenu B Lal
Dec 4, 2014·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
Dec 9, 2014·Human Vaccines & Immunotherapeutics·Michelle H Moniz, Richard H Beigi

❮ Previous
Next ❯

Citations

Dec 15, 2015·The Pediatric Infectious Disease Journal·Mark A KatzRobert F Breiman
Sep 1, 2015·Vaccine·Philipp LambachJustin R Ortiz
May 5, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sonja J OlsenAnonh Xeuatvongsa
Jun 2, 2016·Human Vaccines & Immunotherapeutics·Jennifer A BeelerSaad B Omer
Aug 30, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C Chiu
Jun 3, 2018·Influenza and Other Respiratory Viruses·Stacy ToddMaciej F Boni
Jan 29, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Aldiouma DialloJohn C Victor
Jun 23, 2019·Expert Review of Vaccines·Justin R Ortiz, Kathleen M Neuzil
Aug 5, 2017·Current Opinion in Infectious Diseases·Justin R Ortiz, Kathleen M Neuzil
Jun 19, 2018·Emerging Infectious Diseases·Joseph BreseeUNKNOWN WHO Working Group on the Burden of Influenza Disease
Feb 5, 2019·The Journal of Infectious Diseases·Justin R Ortiz, Kathleen M Neuzil
Dec 22, 2019·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Philippe BuchyJohn S Tam
May 6, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Justin R OrtizKathleen M Neuzil
May 20, 2017·The Lancet Infectious Diseases·Mark C SteinhoffJames M Tielsch

❮ Previous
Next ❯

Software Mentioned

GISRS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.